Breast cancer genomics and immuno-oncological markers to guide immune therapies.

Hammerl, D; Smid, M; Timmermans, A M; Sleijfer, S; Martens, J W M; Debets, R

Hammerl, D; Smid, M; Timmermans, A M; Sleijfer, S; Martens, J W M; Debets, R.

Afiliação

Hammerl D; Department of Medical Oncology, Erasmus MC - Cancer Institute, Rotterdam, the Netherlands.
Smid M; Department of Medical Oncology, Erasmus MC - Cancer Institute, Rotterdam, the Netherlands.
Timmermans AM; Department of Medical Oncology, Erasmus MC - Cancer Institute, Rotterdam, the Netherlands.
Sleijfer S; Department of Medical Oncology, Erasmus MC - Cancer Institute, Rotterdam, the Netherlands.
Martens JWM; Department of Medical Oncology, Erasmus MC - Cancer Institute, Rotterdam, the Netherlands.
Debets R; Department of Medical Oncology, Erasmus MC - Cancer Institute, Rotterdam, the Netherlands. Electronic address: j.debets@erasmusmc.nl.

Semin Cancer Biol ; 52(Pt 2): 178-188, 2018 10.

Article em En | MEDLINE | ID: mdl-29104025

Assuntos

Biomarcadores Tumorais/imunologia; Neoplasias da Mama/genética; Neoplasias da Mama/terapia; Neoplasias da Mama/imunologia; Neoplasias da Mama/patologia; Feminino; Genômica/métodos; Humanos; Imunoterapia/métodos; Oncologia/métodos; Prognóstico

Palavras-chave

Antigens; Breast cancer; Immune evasive mechanisms; Immune-oncological markers; Immunotherapy; TILs

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Semin Cancer Biol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google